Multiple Sclerosis: Diagnostic Methods

Multiple Sclerosis (MS) is a demyelinating autoimmune disease of the CNS, resulting in symptoms including optic neuritis and motor weakness. Here is the latest research on development and application of methods for diagnosis of MS.

January 12, 2021
Open Access

Primary Progressive Multiple Sclerosis Under Anti-TNFα Treatment: A Case Report

Journal of Central Nervous System Disease
Aniello IovinoRosa Iodice
January 11, 2021

Altered structural networks in neuromyelitis optica spectrum disorder related with cognition impairment and clinical features

Multiple Sclerosis and Related Disorders
Qiao ZhengYongmei Li
January 15, 2021

Association of Gray Matter Atrophy Patterns with Clinical Phenotype and Progression in Multiple Sclerosis

Maria A RoccaMAGNIMS study group
January 19, 2021
Open Access

Development and Implementation of a Patient Registry: The Experience of a Multiple Sclerosis Center in Portugal

Acta Médica Portuguesa
João De SáAna Macedo
January 16, 2021
Open Access

Synthesis and Pharmacological Evaluation of Fluorinated Quinoxaline-Based κ-Opioid Receptor (KOR) Agonists Designed for PET Studies

Giovanni TangherliniBernhard Wünsch
January 15, 2021

Preventing multiple sclerosis misdiagnosis using the "central vein sign": A real-world study

Multiple Sclerosis and Related Disorders
Marwa KaiseyNancy L Sicotte
January 11, 2021
Open Access

Optic neuritis of MOG-IgG-associated autoimmune disorders: a case report

BMC Ophthalmology
Tiantian LiXiaobo Zhu
January 21, 2021
Open Access

Clinical feasibility of longitudinal lateral ventricular volume measurements on T2-FLAIR across MRI scanner changes.

NeuroImage. Clinical
Dejan JakimovskiMichael G Dwyer
January 19, 2021
Open Access

Isolated neurosarcoidosis mimicking multiple sclerosis

Neurosciences : the Official Journal of the Pan Arab Union of Neurological Sciences
Yaser M Al Malik
January 14, 2021

Mind the gap: from neurons to networks to outcomes in multiple sclerosis

Nature Reviews. Neurology
Declan T ChardMAGNIMS study group
January 18, 2021
Open Access

N-acetylglucosamine drives myelination by triggering oligodendrocyte precursor cell differentiation

The Journal of Biological Chemistry
Michael SyMichael Demetriou
January 15, 2021
Open Access

Simultaneous lesion and brain segmentation in multiple sclerosis using deep neural networks

Scientific Reports
Richard McKinleyRoland Wiest
January 8, 2021
Open Access

Axon-myelin unit blistering as early event in MS normal appearing white matter

Annals of Neurology
Antonio LuchicchiJeroen J G Geurts
January 16, 2021
Open Access

Comparison of multi echo T2 relaxation and steady state approaches for myelin imaging in the central nervous system

Scientific Reports
Adam V DvorakShannon H Kolind

Sign up to follow this feed and discover related papers.

Related Feeds

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Acute Hemorrhagic Leukoencephalitis

Acute hemorrhagic leukoencephalitis is a rare form of acute disseminated encephalomyelitis characterized by acute inflammation in the brain and spinal cord that causes demyelination and bleeding. It is often fatal, although treatment with immunosuppressives and plasma exchange can be helpful. Find the latest research on acute hemorrhagic leukoencephalitis here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Artificial Heart & Ventricular Assist Devices

Total artificial hearts (TAH) and ventricular assist devices (VADs) provide cardiac support for patients with end-stage heart disease and have significantly improved the survival of these patients. Discover the latest research on Artificial Heart and Ventricular Assist Devices here.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Cardiac Electrophysiology

Cardiac electrophysiology is the study of electrical activities of the heart and includes the assessment, diagnosis, and treatment of cardiac events. Find the latest research on cardiac electrophysiology here.

Cardiac Glycosides

Cardiac glycosides are a diverse family of naturally derived compounds that bind to and inhibit na+/k+-atpase. Discover the latest research on cardiac glycosides heres.

Cardiac Organoids

Cardiac organoids are 3D organ-like structures that can be derived from patients with cardiovascular diseases and are important disease models for drug discovery. Discover the latest research on Cardiac Organoids here.

© 2021 Meta ULC. All rights reserved